The U.S. Transportation Security Administration expects to screen more than 14 million people at airports during Labor Day holiday weekend, with Friday projected to be the busiest day.
: With Hurricane Idalia arriving, a former Floridian remembers the stress of storm season
It’s not just living through the winds and rain — it’s dealing with the horrendous aftermath
The Margin: As Hurricane Idalia nears Florida, people are also tracking the ‘Waffle House Index’
This informal index measures how severe a hurricane or other storm is based on whether the local Waffle House closes or not.
Commodities Corner: Why Hurricane Idalia hasn’t supported U.S. natural-gas prices
U.S. natural-gas futures settle lower on Tuesday, on track to post a loss for the month, with Hurricane Idalia potentially having little impact on energy production, but poised to dent power demand in the Gulf region.
Earnings Results: HP’s stock tumbles after mixed results, cautious outlook
HP Inc.’s stock skidded more than 10% in extended trading Tuesday after the computing giant reported mixed results and offered a cautious outlook.
Earnings Results: Box’s stock is falling on light guidance
Box Inc. on Tuesday reported quarterly results that barely topped analyst revenue and earnings estimates and offered weak guidance.
: Nvidia’s stock closes at record high, sending AI-chip maker to $1.2 trillion market cap
Nvidia shares are back on track to try to turn in their best year ever after closing at a record Tuesday, as the company reached a $1.2 trillion market cap.
Crypto: Are bitcoin ETFs coming? Here’s what Grayscale’s court win means for the crypto industry
A U.S. federal court on Tuesday ordered the Securities and Exchange Commission to vacate its rejection of Grayscale Investments’ application to convert its Bitcoin Trust product into an exchange-traded fund and the crypto industry is celebrating.
: The 30-year mortgage rate has surpassed 7%, but some buyers are only paying 6%. Here’s how they do it.
Mortgage rates have surged to 20-year highs, and are poised to rise even further.
: Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
Merck, Johnson & Johnson and Amgen are among the first drugmakers to have products chosen for a contentious initiative to rein in prescription-drug costs.
- « Previous Page
- 1
- …
- 223
- 224
- 225
- 226
- 227
- …
- 1275
- Next Page »